- Home
- CLLS vs ELVA Comparison
CLLS vs ELVA Comparison
Compare CLLS & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- ELVA
- Stock Information
- Founded
- CLLS 1999
- ELVA 1996
- Country
- CLLS France
- ELVA Canada
- Employees
- CLLS N/A
- ELVA N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- ELVA
- Sector
- CLLS Health Care
- ELVA
- Exchange
- CLLS Nasdaq
- ELVA Nasdaq
- Market Cap
- CLLS 143.4M
- ELVA 125.5M
- IPO Year
- CLLS 2007
- ELVA N/A
- Fundamental
- Price
- CLLS $2.95
- ELVA $4.86
- Analyst Decision
- CLLS Buy
- ELVA Strong Buy
- Analyst Count
- CLLS 1
- ELVA 5
- Target Price
- CLLS $4.00
- ELVA $6.10
- AVG Volume (30 Days)
- CLLS 310.2K
- ELVA 208.1K
- Earning Date
- CLLS 08-04-2025
- ELVA 08-13-2025
- Dividend Yield
- CLLS N/A
- ELVA N/A
- EPS Growth
- CLLS N/A
- ELVA N/A
- EPS
- CLLS N/A
- ELVA N/A
- Revenue
- CLLS $54,747,000.00
- ELVA $48,016,000.00
- Revenue This Year
- CLLS N/A
- ELVA $55.29
- Revenue Next Year
- CLLS $4.90
- ELVA $63.69
- P/E Ratio
- CLLS N/A
- ELVA N/A
- Revenue Growth
- CLLS 351.26
- ELVA N/A
- 52 Week Low
- CLLS $1.10
- ELVA $1.67
- 52 Week High
- CLLS $3.10
- ELVA $5.14
- Technical
- Relative Strength Index (RSI)
- CLLS 69.22
- ELVA 69.55
- Support Level
- CLLS $2.43
- ELVA $4.35
- Resistance Level
- CLLS $3.10
- ELVA $5.14
- Average True Range (ATR)
- CLLS 0.27
- ELVA 0.31
- MACD
- CLLS 0.08
- ELVA 0.08
- Stochastic Oscillator
- CLLS 88.72
- ELVA 82.39
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.